Trial Profile
Dual Triggering With Gonadotropin-releasing Hormone Agonist and Standard Dose Human Chorionic Gonadotropin in Patients With a High Immature Oocyte Rate
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Choriogonadotropin alfa (Primary) ; Triptorelin (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- 07 Jul 2016 New trial record